Russia is close to creating cancer vaccines, says President Putin Animal studies are completed successfully, with clinical trials planned. The IIT-Madras researchers are currently working on addressing the safety and cost issues which are major challenges in the existing cancer medicines.
"We are looking at a two to three-year window for bringing the formulations to market," R Nagarajan added. Tamil Nadu bans cotton candy sale over cancer concerns Animal validation to adjust the dosage (GLP phase) and efficacy studies (non-GLP phase) have been carried out through funding support from IIT Madras Distinguished Alumnus Awardee and Infosys Co-Founder Gopalakrishnan through Pratiksha Trust.
Gopalakrishnan on the X platform wrote, "IIT Madras researchers patent use of Indian spices to treat cancer". M Joyce Nirmala, Chief Scientific Officer (Cancer Nanomedicine and Drug Design Laboratory), IIT Madras, said the patented Indian spice-based nano-formulations have proven effective in many common types of cancers through in-vitro studies.
"This cancer nanomedicine is being developed to reduce the cost and pain of cancer treatment and also to overcome the toxic side effects seen in the existing cancer treatments," Nirmala added. We must break the silence on the silent killer that cervical cancer is The IIT Madras officials said in the last two decades, nano-oncology has shown promise as an emerging strategy in cancer therapy, diagnosis, and prevention, demonstrating positive outcomes in research and clinical trials.
Chemotherapy has been in use as a treatment strategy since 1930 with other common treatment options being radiotherapy and surgery. However, conventional treatment options are often associated with pain, toxic side
. Read more on livemint.com